New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation

Bioorg Med Chem Lett. 2016 Aug 1;26(15):3730-4. doi: 10.1016/j.bmcl.2016.05.074. Epub 2016 May 26.

Abstract

A new family of indolizine-chalcones was designed, synthesized and screened for the inhibitory potential on human farnesyltransferase in vitro to identify potent antitumor agents. The most active compound was phenothiazine 2a, exhibiting an IC50 value in the low nanomolar range, similar to that of known FTI-276, highly potent farnesyltransferase inhibitor. The newly synthesized indolizine-chalcones 2a-d constitute the most efficient inhibitors of farnesyltransferase bearing a phenothiazine unit known to date.

Keywords: Antitumor agent; Chalcone; Farnesyltransferase inhibitor; Indolizine; Phenothiazine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chalcones / chemistry
  • Chalcones / pharmacology*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Farnesyltranstransferase / antagonists & inhibitors*
  • Farnesyltranstransferase / metabolism
  • Humans
  • Indolizines / chemistry
  • Indolizines / pharmacology*
  • Molecular Structure
  • Structure-Activity Relationship

Substances

  • Chalcones
  • Enzyme Inhibitors
  • Indolizines
  • indolizine
  • Farnesyltranstransferase